SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug NTR-1011 tested for safety in lupus and arthritis patients
Disease control CompletedThis study tested a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The main goal was to see if the drug is safe and to find the best dose. Researchers also looked at how the drug works in the body and if it shows any early signs of he…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
Experimental CAR T-Cell therapy targets tough lupus cases
Disease control CompletedThis early-stage trial tested a new treatment for people with severe lupus that did not get better with standard medicines. The treatment uses a patient's own immune cells, modified to attack faulty B cells. Only 3 adults took part, and the main goal was to check safety and see i…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 08, 2026 13:08 UTC